Anne Marie Boustani, MD
Assistant Professor of Clinical Radiology and Biomedical Imaging
Research & Publications
Biography
News
Research Summary
Research interests include using nuclear medicine techniques to diagnose and treat neuroendocrine tumors and using novel diagnostic imaging agents for improving cancer diagnosis and ultimately helping lead to improved treatments.
Coauthors
Selected Publications
- Molecular Imaging of the Immuno-metabolic Cross-Talk reveals Resistance Mechanisms in a Rabbit Liver Cancer Model.Radiology
- Opening Up the Ovary: A Multimodality Approach to Imaging Ovarian Neoplasms with Pathology Correlation.Radiographics
- Diagnostic Approach to Primary Retroperitoneal Pathologies: What the Radiologist Needs to Know.Abdominal Radiology
- Molecular imaging of prostate cancer.Boustani AM, Pucar D, Saperstein L. Molecular imaging of prostate cancer. The British Journal Of Radiology 2018, 91:20170736.
- Molecular MRI of the Immuno-Metabolic Interplay in a Rabbit Liver Tumor Model: A Biomarker for Resistance Mechanisms in Tumor-targeted Therapy?Savic LJ, Doemel LA, Schobert IT, Montgomery RR, Joshi N, Walsh JJ, Santana J, Pekurovsky V, Zhang X, Lin M, Adam L, Boustani A, Duncan J, Leng L, Bucala RJ, Goldberg SN, Hyder F, Coman D, Chapiro J. Molecular MRI of the Immuno-Metabolic Interplay in a Rabbit Liver Tumor Model: A Biomarker for Resistance Mechanisms in Tumor-targeted Therapy? Radiology 2020, 296:575-583.
- Diagnostic approach to primary retroperitoneal pathologies: what the radiologist needs to know.Czeyda-Pommersheim F, Menias C, Boustani A, Revzin M. Diagnostic approach to primary retroperitoneal pathologies: what the radiologist needs to know. Abdominal Radiology (New York) 2021, 46:1062-1081.
- Superior Pituitary Border Analysis in Immunotherapy-Induced Hypophysitis.Pucar D, Boustani AM, Bronen RA, Saperstein L. Superior Pituitary Border Analysis in Immunotherapy-Induced Hypophysitis. Clinical Nuclear Medicine 2018, 43:284-286.
- Altered FDG Biodistribution in Subcutaneous White Fat on PET/CT Following l-Asparaginase Chemotherapy.Young CR, Kulon ME, Boustani AM, Pucar D. Altered FDG Biodistribution in Subcutaneous White Fat on PET/CT Following l-Asparaginase Chemotherapy. Clinical Nuclear Medicine 2021, 46:e179-e180.